The #1 Mistake Marijuana Stock Investors Make

Hexo Corp. (TSX:HEXO)(NYSE:HEXO) and The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) offer big gains in the future, but don’t make the mistake of holding too much in your portfolio.

| More on:
edit Jars of marijuana

Image source: Getty Images

The hype over marijuana stocks is creating overzealous investors. This budding industry is drawing so much attention because of the promise of explosive growth. Since the legalization of adult-use marijuana last October, however, some investors lost money in two of the most promising pot stocks.

Hexo (TSX:HEXO)(NYSE:HEXO) and Green Organic Dutchman (TSX:TGOD) had steep drops in recent months. Many investors in the two pot stocks made the number one mistake when investing in marijuana: too much of their portfolio was weighted towards marijuana, and now they are paying the price.

Sputtering growth

Hexo is one of the marijuana stocks that had huge declines this year. The stock soared by 113% to $11.11 from early January to late April. Since then, the high-flying pot stock went on a free fall. The latest price of Hexo is a low $5.39.

So, why is Hexo sputtering? The Quebec cannabis giant is at the stage of building infrastructure and production capacity. Hexo is also expanding its distribution channels and market presence outside Quebec.

While Hexo is working to grow top-line revenue, it’s also burning cash at the rate of $100 million a year. The company’s total gross revenue in Q3 2019 grew to $15.9 million or 11.8 times better versus the same quarter in 2018. The figure could double in Q4 2019 as a result of its expansion initiatives.

Hexo’s distinct business model would be its saving grace come December this year. Its partnership with Molson Coors brewing is a niche play because the main focus of Hexo is on edibles and beverages, which have a broader customer appeal.

One step backwards, two steps forward

At the start of September, Aurora Cannabis sold its significant holdings of TGOD shares. TGOD is downplaying Aurora’s hasty move, despite the 16.5% drop after the announcement. The company is in denial, although there are negative implications.

The stock went as high as $5.48 in mid-March but is lower by 57.3% today. Losing the support of Aurora somehow dampens the future of TGOD in the eyes of investors. Many of the primary industry players are reporting significant revenues except for TGOD.

TGOD’s CEO Brian Athaide said that losing Aurora brings more positives than negatives. Reserving its premium organic cannabis for Aurora would mean lower average prices and margins. Thus Aurora’s departure would improve the company’s revenue and margin potential.

Management remains optimistic about fulfilling its business objectives and creating value for shareholders. TGOD made a significant step last month to broaden the investor base, increase access for international investors, and to grow further. The company’s application to list on the Nasdaq is now pending.

Promising future

Hexo and TGOD are not out of the game. The lesson is here is that you must think long term if you want to invest in the two promising stocks. If you’re not ready for the wild price swings, you must limit your exposure.

Since your chances of losing money are high, keep only a small percentage of Hexo and TGOD in your portfolio. You would be in high spirits or desolate at times, depending on how the stocks perform under immense volatility. But in the long term, your small investment in Hexo and TGOD could deliver massive gains.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »